Daxor Corporation Announces a Study by the University of Miami/Jackson Memorial Hospital of Chronic Fatigue Syndrome Using the BVA-100.Business Editors/Health/Medical Writers NEW YORK--(BUSINESS WIRE)--April 22, 2004 Daxor Corporation, (AMEX AMEX See: American Stock Exchange : DXR), a leading medical instrumentation and biotechnology company, today announced that the receipt of an agreement from the laboratory of Dr. Barry Hurwitz of the Behavioral Medicine Research Center, University of Miami This article is about the university in Coral Gables, Florida. For the university in Oxford, Ohio, see Miami University. The University of Miami (also known as Miami of Florida,[2] UM,[3] or just The U , to use the BVA-100 Blood Volume Analyzer in conjunction with Jackson Memorial Hospital Jackson Memorial Hospital (also known as "Jackson" or abbreviated "JMH") is a non-profit, tertiary care teaching hospital and the major teaching hospital of the University of Miami Leonard M. Miller School of Medicine in Miami, Florida. . The equipment will be used in the study of Chronic Fatigue Syndrome chronic fatigue syndrome (CFS), collection of persistent, debilitating symptoms, the most notable of which is severe, lasting fatigue. In other countries it is known variously as myalgic encephalomyelitis, chronic fatigue and immune dysfunction syndrome, and in the Department of Nuclear Medicine, under the supervision of Dr. George Sfakianakis, Chief of Nuclear Medicine at Jackson Memorial Hospital. The study will be conducted by Dr. Barry Hurwitz, Professor of Psychology, Medicine, and Biomedical Engineering at the Behavioral Medicine Research Center. The University of Miami is the largest, most comprehensive private research university in the southeastern United States with a well-earned reputation for academic excellence. The study is sponsored in part by the National Institutes of Health (NIH "Not invented here." See digispeak. NIH - The United States National Institutes of Health. ), National Heart, Lung and Blood Institute. Included in the study will be investigation of the benefits of the use of epoetin alpha or PROCRIT, manufactured by Ortho Biotech Products, L.P., which increases the red blood cell red blood cell: see blood. volume of patients. This study will utilize the BVA-100 Blood Volume Analyzer, the only semi-automated instrument, and its associated kit, approved by the FDA. The Chronic Fatigue Syndrome is said to affect over 1 million Americans. In its more severe forms it may be so disabling that individuals are unable to engage in normal activity, and many of them are on disability. Studies have suggested that susceptible individuals may experience sudden drops of blood pressure which may trigger fainting. A preliminary study has suggested that some of these individuals may suffer from low blood volume, which cannot be detected by the standard tests such as hematocrit or hemoglobin used to detect anemia. Low blood volume, and particularly low red cell volume, may cause an individual to be susceptible to feelings of weakness and fatigue. It is well known that patients who are significantly red cell volume depleted may have profound symptoms of weakness. This study will evaluate the frequency to which low blood volume plays a role in the Chronic Fatigue Syndrome and the extent to which its treatment will ameliorate the symptoms. Dr. Joseph Feldschuh, President of Daxor, stated that "We are pleased that a distinguished university such as the University of Miami will be utilizing the BVA-100 in this important research work." Daxor Corporation manufactures and markets the BVA-100, a semi-automated Blood Volume Analyzer. The BVA-100 is used in conjunction with a single use diagnostic kit. It is the first instrument to provide rapid, direct measurement of a patient's blood volume with a high degree of precision. Among nationally renowned hospitals which have purchased the BVA-100 Blood Volume Analyzer are the Mayo Clinic, the Cleveland Clinic, NIH, and New York University New York University, mainly in New York City; coeducational; chartered 1831, opened 1832 as the Univ. of the City of New York, renamed 1896. It comprises 13 schools and colleges, maintaining 4 main centers (including the Medical Center) in the city, as well as the Medical Center, as well as other major medical institutions. Among the other conditions in which the blood volume analyzer has been used are congestive heart failure congestive heart failure, inability of the heart to expel sufficient blood to keep pace with the metabolic demands of the body. In the healthy individual the heart can tolerate large increases of workload for a considerable length of time. , syncope syncope Effect of temporary impairment of blood circulation to a part of the body. It is often used as a synonym for fainting, which is loss of consciousness due to inadequate blood flow to the brain. , and septic shock. More information about the BVA-100 and other Daxor products and services can be found at www.daxor.com. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion